American Express’s card rules for merchants prompted debate at the Supreme Court Monday, February 26, as the justices considered whether to revive a government antitrust lawsuit challenging the company’s approach, reported the Wall Street Journal.
The case centers on the fees credit-card companies charge to retailers for processing transactions. American Express’s “anti-steering” provisions bar retailers from doing anything like offering discounts to encourage the use of competing cards that are less expensive. As a result, the government says, stores are stuck with higher fees, which are passed on to consumers, even those that don’t use American Express cards.
Supreme Court justices appeared divided over whether rules American Express imposes on merchants violate antitrust laws. During an hour-long oral argument, Justices Sonia Sotomayor and Neil Gorsuch dominated questions from the bench and offered different views of the case.
Justices Sonia Sotomayor and Elena Kagan, signaled at arguments that they back the government’s claim that the company’s rules harm competition by preventing retailers from encouraging customers to use lower-cost cards, reported Bloomberg. Merchants can’t offer consumers a choice between earning a discount by using another card or sticking with an American Express card so they can earn rewards, Sotomayor said.
Justice Gorsuch, for his part, pressed an attorney for Ohio, one of 11 states that brought the challenge to the AmEx rules to the high court. He suggested AmEx, which has a smaller market share than Visa and Mastercard, doesn’t have the market power necessary to impose anticompetitive terms. He also said AmEx card rewards provided notable benefits to consumers reported the Wall Street Journal.
The outcome of the case wasn’t clear, because a majority of justices didn’t signal their views and both sides received tough questions from the court, concluded the Wall Street Journal.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas